Comparison
3p Syndrome C4706503 vs 17 20 Lyase Deficiency Isolated Included CN372394
Clinical comparison between 3P Syndrome and 17 20 Lyase Deficiency Isolated Included CN372394 for differential diagnosis and treatment planning.
3p Syndrome C4706503
A rare chromosomal disorder involving deletion of genetic material from chromosome 3. It causes distinctive facial features, growth delays, and intellectual disability. Care involves managing developmental and medical complications.
17 20 Lyase Deficiency Isolated Included CN372394
6 comparison axes
Onset
3p Syndrome C4706503
0-0
17 20 Lyase Deficiency Isolated Included CN372394
0-16
Onset patterns differ
Severity
3p Syndrome C4706503
severe
17 20 Lyase Deficiency Isolated Included CN372394
severe
Different severity levels
Chronic
3p Syndrome C4706503
Chronic
17 20 Lyase Deficiency Isolated Included CN372394
Chronic
Differing course
Communicable
3p Syndrome C4706503
No
17 20 Lyase Deficiency Isolated Included CN372394
No
Different transmission
Body System
3p Syndrome C4706503
congenital
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
Same/different system
Category
3p Syndrome C4706503
genetic
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
Different category
Bottom line
3p-syndrome-C4706503 and 17-20-lyase-deficiency-isolated-included-CN372394 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3p Syndrome C4706503 | 17 20 Lyase Deficiency Isolated Included CN372394 | Discriminating power |
|---|---|---|---|
| Development and growth | May include congenital growth delay and intellectual disability. | Sex-steroid deficiency may predominate; developmental disability is not established. | Moderate |
| Genital or pubertal development | Genital or pubertal abnormality is not defining in the supplied description. | May involve undervirilization, delayed puberty, or absent secondary sexual characteristics. | High |
| Congenital pattern | Distinctive facial features and other congenital anomalies may occur. | A characteristic chromosomal dysmorphic pattern is not established. | Moderate |
When to favor each condition
Choose 3p Syndrome C4706503 when
Growth delay with dysmorphic features
This broader congenital pattern fits a chromosomal deletion better than isolated lyase deficiency.
Moderate
Chromosomal testing suggests 3p deletion
A confirmed relevant chromosomal finding supports the left diagnosis after specialist review.
High
Multisystem congenital findings
Multiple anomalies align more with 3p deletion, although overlap is not excluded.
Low
Choose 17 20 Lyase Deficiency Isolated Included CN372394 when
Undervirilization or absent puberty
Disordered sex-steroid development is more consistent with isolated 17,20-lyase deficiency.
Moderate
Steroid results suggest preserved cortisol
Low sex steroids with relatively preserved cortisol may support lyase impairment but are not diagnostic alone.
Moderate
Related gene testing is considered
CYP17A1, CYB5A, or related causes require specialist selection; no single cause is established here.
Low
How key tests differ
| Test | 3p Syndrome C4706503 | 17 20 Lyase Deficiency Isolated Included CN372394 | Interpretation |
|---|---|---|---|
| Karyotype or chromosomal microarray | May detect deletion involving 3p. | Usually nondiagnostic for this endocrine disorder. | A chromosomal result supports, but does not by itself prove, the clinical diagnosis. |
| Serum steroid profile | No specific steroid abnormality is established. | May show low sex steroids with relatively preserved cortisol; cutoffs are not supplied. | Abnormal results are findings requiring endocrine interpretation, not a diagnosis. |
| Targeted genetic testing | May confirm a relevant 3p chromosomal change. | May identify a variant affecting lyase activity. | Variant significance and causation require clinical and laboratory correlation. |
Prognosis comparison
3p Syndrome C4706503
- Outcome
- Often chronic developmental and medical needs; individual outcome and mortality are not established here.
- Factors
- Deletion extent, anomalies, developmental support, and medical complications.
17 20 Lyase Deficiency Isolated Included CN372394
- Outcome
- A chronic endocrine condition whose puberty and fertility effects vary; prognosis is incompletely established.
- Factors
- Degree of sex-steroid deficiency, genetic cause, recognition timing, and specialist care.
Time frame: From birth or childhood into adulthood, with review during development and puberty.
Diagnostic confirmation, associated findings, hormone results, care access, and individual response.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental complications | Intellectual disability and growth delay may need long-term support. Cognitive complications are not established from supplied data. Developmental outcomes should be assessed individually. |
| Reproductive endocrine effects | Not described as a core feature. Delayed puberty, sex-hormone deficiency, or fertility concerns may occur. Care is individualized; no treatment dose is established here. |
| Other congenital anomalies | Additional organ anomalies may require surveillance. Systemic congenital anomalies are not established for the isolated form. Screening should follow observed clinical findings. |
Patient education highlights
- HighDifferent causes
One is a chromosome deletion and the other a rare hormone-synthesis disorder. Neither is contagious.
- HighTests versus diagnosis
An abnormal chromosome or hormone result needs clinician interpretation before diagnosis.
- MediumFollow-up
Genetics, endocrinology, development, and puberty or fertility counseling may be relevant.